Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Investigating brain biomarkers to predict clinical response in treatment-resistant late-life depression

FY 2017-18

Summary
Many Canadians are affected by mood and anxiety disorders. These disorders are the most common mental illnesses people face. However, front-line drug therapies do not work well for a great majority of older adults with depression. Poor scientific understanding of late-life depression makes it hard to find new, effective treatments. Researching how to better treat people with reatment-resistant late-life depression (TR LLD) represents a top public health priority.A previous clinical trial found that an antipsychotic medication called aripiprazole was effective at reducing symptoms in older adults with TR LLD. Using brain imaging, we will determine whether brain markers can predict good treatment response to aripiprazole in TR LLD. Knowing this will help us better screen and determine the best treatment options for people at risk of TR LLD. We hope to help Canadians by reducing the burden and suffering experienced by people with TR LLD.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
386312
Name
Chan Nathan K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating brain biomarkers to predict clinical response in treatment-resistant late-life depression
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aripiprazole; Biomarkers; Clinical Science; Clinical Trial; Geriatric Psychiatry; Gerontology; Late-Life Depression; Magnetic Resonance Imaging; Neuroimaging; Treatment Resistant
Abstract
Many Canadians are affected by mood and anxiety disorders. These disorders are the most common mental illnesses people face. However, front-line drug therapies do not work well for a great majority of older adults with depression. Poor scientific understanding of late-life depression makes it hard to find new, effective treatments. Researching how to better treat people with reatment-resistant late-life depression (TR LLD) represents a top public health priority.A previous clinical trial found that an antipsychotic medication called aripiprazole was effective at reducing symptoms in older adults with TR LLD. Using brain imaging, we will determine whether brain markers can predict good treatment response to aripiprazole in TR LLD. Knowing this will help us better screen and determine the best treatment options for people at risk of TR LLD. We hope to help Canadians by reducing the burden and suffering experienced by people with TR LLD.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chan, Nathan K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~